These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 8222328)

  • 1. Localization of tumour necrosis factor-alpha (TNF-alpha) and its receptors in normal and psoriatic skin: epidermal cells express the 55-kD but not the 75-kD TNF receptor.
    Kristensen M; Chu CQ; Eedy DJ; Feldmann M; Brennan FM; Breathnach SM
    Clin Exp Immunol; 1993 Nov; 94(2):354-62. PubMed ID: 8222328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distribution of interleukin 1 receptor antagonist protein (IRAP), interleukin 1 receptor, and interleukin 1 alpha in normal and psoriatic skin. Decreased expression of IRAP in psoriatic lesional epidermis.
    Kristensen M; Deleuran B; Eedy DJ; Feldmann M; Breathnach SM; Brennan FM
    Br J Dermatol; 1992 Oct; 127(4):305-11. PubMed ID: 1419749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated tumour necrosis factor-alpha (TNF-alpha) biological activity in psoriatic skin lesions.
    Ettehadi P; Greaves MW; Wallach D; Aderka D; Camp RD
    Clin Exp Immunol; 1994 Apr; 96(1):146-51. PubMed ID: 8149659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo effects of cytokines on psoriatic skin grafted on nude mice: involvement of the tumour necrosis factor (TNF) receptor.
    Gilhar A; David M; Kalish RS; Weisinger G
    Clin Exp Immunol; 1996 Oct; 106(1):134-42. PubMed ID: 8870711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidermal expression of interleukin-6 and tumour necrosis factor-alpha in normal and immunoinflammatory skin states in humans.
    Oxholm A
    APMIS Suppl; 1992; 24():1-32. PubMed ID: 1567657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Normal response to tumor necrosis factor-alpha and transforming growth factor-beta by keratinocytes in psoriasis.
    Malkani AK; Baker BS; Garioch JJ; Powles AV; Lewis HM; Valdimarsson H; Fry L
    Exp Dermatol; 1993 Oct; 2(5):224-30. PubMed ID: 8162342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TNFalpha and its receptors in psoriatic skin, before and after treatment with etanercept.
    Caldarola G; De Simone C; Carbone A; Tulli A; Amerio P; Feliciani C
    Int J Immunopathol Pharmacol; 2009; 22(4):961-6. PubMed ID: 20074459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular localization of interleukin-8 and its inducer, tumor necrosis factor-alpha in psoriasis.
    Nickoloff BJ; Karabin GD; Barker JN; Griffiths CE; Sarma V; Mitra RS; Elder JT; Kunkel SL; Dixit VM
    Am J Pathol; 1991 Jan; 138(1):129-40. PubMed ID: 1702929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of cytokines and their receptors by psoriatic fibroblasts. II. decreased TNF receptor expression.
    Debets R; Hegmans JP; Buurman WA; Benner R; Prens EP
    Cytokine; 1996 Jan; 8(1):80-8. PubMed ID: 8742070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mast cells of psoriatic and atopic dermatitis skin are positive for TNF-alpha and their degranulation is associated with expression of ICAM-1 in the epidermis.
    Ackermann L; Harvima IT
    Arch Dermatol Res; 1998 Jul; 290(7):353-9. PubMed ID: 9749989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased expression of TRAIL and its death receptors DR4 and DR5 in plaque psoriasis.
    Peternel S; Prpić-Massari L; Manestar-Blažić T; Brajac I; Kaštelan M
    Arch Dermatol Res; 2011 Aug; 303(6):389-97. PubMed ID: 21279373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential regulation of tumour necrosis factor receptors (TNF-R) by IL-4; upregulation of P55 and P75 TNF-R on synovial joint mononuclear cells.
    Cope AP; Gibbons DL; Aderka D; Foxwell BM; Wallach D; Maini RN; Feldmann M; Brennan FM
    Cytokine; 1993 May; 5(3):205-12. PubMed ID: 8218932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CCL7 contributes to the TNF-alpha-dependent inflammation of lesional psoriatic skin.
    Brunner PM; Glitzner E; Reininger B; Klein I; Stary G; Mildner M; Uhrin P; Sibilia M; Stingl G
    Exp Dermatol; 2015 Jul; 24(7):522-8. PubMed ID: 25828150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered binding of Ulex europaeus I lectin to psoriatic epidermis.
    Kariniemi AL; Holthöfer H; Miettinen A; Virtanen I
    Br J Dermatol; 1983 Nov; 109(5):523-9. PubMed ID: 6357263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inducibility and expression of microvascular endothelial adhesion molecules in lesional, perilesional, and uninvolved skin of psoriatic patients.
    Petzelbauer P; Pober JS; Keh A; Braverman IM
    J Invest Dermatol; 1994 Sep; 103(3):300-5. PubMed ID: 7521374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential expression of phosphorylated NF-kappaB/RelA in normal and psoriatic epidermis and downregulation of NF-kappaB in response to treatment with etanercept.
    Lizzul PF; Aphale A; Malaviya R; Sun Y; Masud S; Dombrovskiy V; Gottlieb AB
    J Invest Dermatol; 2005 Jun; 124(6):1275-83. PubMed ID: 15955104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The tumour necrosis factor family of receptors/ligands in the serum of patients with rheumatoid arthritis.
    Robak T; Gladalska A; Stepień H
    Eur Cytokine Netw; 1998 Jun; 9(2):145-54. PubMed ID: 9681390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Upregulation of p55 and p75 receptors mediating TNF-alpha transport across the injured blood-spinal cord barrier.
    Pan W; Csernus B; Kastin AJ
    J Mol Neurosci; 2003; 21(2):173-84. PubMed ID: 14593216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of involucrin in psoriatic epidermal keratinocytes: the roles of ERK1/2 and GSK-3β.
    Chen JQ; Man XY; Li W; Zhou J; Landeck L; Cai SQ; Zheng M
    Cell Biochem Biophys; 2013 Jul; 66(3):523-8. PubMed ID: 23283814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leukocyte infiltration and mRNA expression of IL-20, IL-8 and TNF-R P60 in psoriatic skin is driven by TNF-alpha.
    Ogilvie AL; Lüftl M; Antoni C; Schuler G; Kalden JR; Lorenz HM
    Int J Immunopathol Pharmacol; 2006; 19(2):271-8. PubMed ID: 16831294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.